Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIOLOGICS "COMING SOON" ADS SHOULD BE PRECLEARED

Executive Summary

BIOLOGICS "COMING SOON" ADS SHOULD BE PRECLEARED by FDA's Advertising & Promotional Labeling Staff as part of the introductory package of advertising materials, Center for Biologics Evaluation & Research APLS Director William Purvis explained at a recent Food & Drug Law Institute meeting. A prepared outline of Purvis' speech states that "coming soon" ads are "just as important as the post-approval campaign, [and have] the potential to convey improper or misleading suggestions about the product before licensure." Therefore, the outline states, "APLS will recommend revising the procedural guide to ensure that this type of advertising and promotion continue to be submitted for review."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel